Netcall (LON:NET) Given “Buy” Rating at Berenberg Bank

Netcall (LON:NET)‘s stock had its “buy” rating reissued by investment analysts at Berenberg Bank in a report issued on Tuesday,Digital Look reports. They currently have a GBX 165 price objective on the stock. Berenberg Bank’s price target indicates a potential upside of 39.83% from the company’s current price.

Separately, Canaccord Genuity Group reaffirmed a “buy” rating and set a GBX 160 target price on shares of Netcall in a report on Wednesday, March 4th. Two equities research analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus price target of GBX 162.50.

Netcall Price Performance

Shares of NET stock traded down GBX 1 during trading hours on Tuesday, hitting GBX 118. 552,754 shares of the company’s stock were exchanged, compared to its average volume of 452,038. The company has a market capitalization of £201.30 million, a PE ratio of 83.10 and a beta of 0.10. The company has a current ratio of 0.55, a quick ratio of 0.88 and a debt-to-equity ratio of 2.06. Netcall has a 12-month low of GBX 94.10 and a 12-month high of GBX 138. The business’s 50 day simple moving average is GBX 120.55 and its 200-day simple moving average is GBX 114.96.

Insider Buying and Selling

In other Netcall news, insider Michael Jackson sold 150,000 shares of the stock in a transaction on Thursday, May 14th. The shares were sold at an average price of GBX 125, for a total transaction of £187,500. 6.39% of the stock is owned by corporate insiders.

About Netcall

Netcall is a UK-based enterprise software company that unites automation and customer engagement in one AI-powered platform. Its Liberty platform makes work easier by digitising processes and simplifying customer interactions in a single, easy-to-use solution that reduces complexity. Today, around 600 organisations across healthcare, government and financial services rely on Netcall for mission‑critical workflows, including two‑thirds of NHS Acute Health Trusts and major enterprises such as Legal & General, Baloise and Santander.